We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Menarini and OBT Sign Major Strategic Collaboration

Strategic alliance for the clinical development and manufacture of a portfolio of novel antibody-based cancer drugs.
News

Complix Receives €1.9 Million IWT Grant

Grant to accelerate development of Alphabodies™ against intracellular disease targets, including cancer.
News

Rockland and LIMR Expand Licensing and Commercialization Relationship

Rockland will market established technologies including the CellCountEZ®, OxPhos™, RadDose™ and the Intracellular ThiolEZ™ assays.
News

NIH-Funded Research Provides New Clues on How ApoE4 Affects Alzheimer's Risk

Researchers found that ApoE4 triggers an inflammatory reaction that weakens the blood-brain barrier.
News

Vermillion Announces CEO Succession Plan

Gail S. Page has resigned from the board of directors.
News

Innova Biosciences Secures Prestigious Development of Prototype Grant

Company has been awarded a development of prototype grant circa £210,000 by the Technology Strategy Board.
News

New Patent Granted in Japan

New patent enhances value of revolutionary new Australian blood clot diagnostic technology.
News

Hangzhou Silan Azure Expands Manufacturing Capacity with Veeco MOCVD

Veeco's TurboDisc® K465i™ MOCVD systems will be used to expand Silan’s manufacturing capacity for HB LEDs.
News

How to Make Stem Cells – Nuclear Reprogramming Moves a Step Forward

The idea of taking a mature cell and removing its identity (nuclear reprogramming) so that it can then become any kind of cell, holds great promise for repairing damaged tissue or replacing bone marrow after chemotherapy.
News

BioLineRx to Conduct Interim Analysis of Phase II/III CLARITY Trial of BL-1020

Results of interim analysis expected in Q1 2013.
Advertisement